Patents by Inventor Willie Whitter

Willie Whitter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists
    Patent number: 7452893
    Abstract: Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.
    Type: Grant
    Filed: August 11, 2004
    Date of Patent: November 18, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Wayne Thompson, Steven D. Young, Brian T. Phillips, Peter Munson, Willie Whitter, Nigel Liverton, Christine Dieckhaus, John Butcher, John A. McCauley, Charles J. McIntyre, Mark E. Layton, Philip E. Sanderson
  • 4-Cycloakylaminopyrazolo pyrimidine nmda/nr2b antagonists
    Publication number: 20070037829
    Abstract: Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.
    Type: Application
    Filed: August 11, 2004
    Publication date: February 15, 2007
    Applicant: MERCK & CO., INC.
    Inventors: Wayne Thompson, Steven Young, Brian Phillips, Peter Munson, Willie Whitter, Nigel Liverton, Christine Dieckhaus, John Butcher, John McCauley, Charles McIntyre, Mark Layton, Philip Sanderson
  • 4-Cycloalkylaminopyrazolo pyrimidine NMDA/NR2B antagonists
    Publication number: 20050054658
    Abstract: Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.
    Type: Application
    Filed: August 12, 2004
    Publication date: March 10, 2005
    Inventors: Wayne Thompson, Steven Young, Brian Phillips, Peter Munson, Willie Whitter, Nigel Liverton, Christine Dieckhaus, John Butcher, John McCauley, Charles McIntyre, Mark Layton, Philip Sanderson
  • 1,4 substituted piperidinyl NMDA/NR2B antagonists
    Publication number: 20030018038
    Abstract: Novel piperidinyl compounds substituted in the 1- and 4-positions are effective as NMDA NR2B antagonists useful for relieving pain.
    Type: Application
    Filed: August 9, 2002
    Publication date: January 23, 2003
    Applicant: Merck & Co., Inc.
    Inventors: Wayne Thompson, David A. Claremon, Peter M. Munson, Janusz Kulagowski, Willie Whitter, Ian Huscroft
  • 1,4 substituted piperidinyl NMDA/NR2B antagonists
    Patent number: 6476041
    Abstract: Novel piperidinyl compounds substituted in the 1- and 4-positions are effective as NMDA NR2B antagonists useful for relieving pain.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: November 5, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Wayne Thompson, David A. Claremon, Peter M. Munson, Janusz Kulagowski, Willie Whitter, Ian Huscroft